SynthesisAlzheimer's research & therapy2024

Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review.

Marlies Oosthoek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.